Molecular diagnosis in lymphoma

Current Oncology Reports

Volumn 6, Issue 5, 2004, Pages 369-379

  Bagg, Adam ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENETICS; IMMUNOPHENOTYPING; LYMPHOMA; MICROSCOPY; TECHNOLOGY;

EID: 4544366095     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-004-0063-9     Document Type: Article

References (51)

1. Davis RE, Staudt LM: Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol 2002, 9:333-338.
2. Staudt LM: Molecular diagnosis of the hematologic cancers. N Engl J Med 2003, 348:1777-1785.
3. Bagg A: Clinical applications of molecular genetic testing in hematologic malignancies: advantages and limitations. Hum Pathol 2003, 34:352-358.
4. van der Velden VH, Hochhaus A, Cazzaniga G, et al.: Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003, 17:1013-1034.
5. Macintyre EA, Delabasse E: Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999, 36:373-389.
6. Bagg A, Braziel RM, Arber DA, et al.: Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays. J Mol Diagn 2002, 4:81-89.
7. Gleissner B, Thiel E: Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies. Expert Rev Mol Diag 2001, 1:191-200.
8. Arber DA, Braziel RM, Bagg A, et al.: Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn 2001, 3:133-140.
9. Hodges E, Krishna MT, Pickard C, Smith JL: Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003, 56:1-11.
10. Greiner TC, Rubocki RJ: Effectiveness of capillary electrophoresis using fluorescent-labeled primers in detecting T-cell receptor gamma gene rearrangements. J Mol Diagn 2002, 4:137-143.
11. Aster JC, Longtine JA: Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 2002, 160:759-763.
12. Albinger-Hegyi A, Hochreutener B, Abdou MT, et al.: High frequency of t(14, 18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 2002, 160:823-832.
13. Gribben JG: Monitoring disease in lymphoma and CLL patients using molecular techniques. Best Pract Res Clin Haematol 2002, 15:179-95.
14. Lopez-Guillermo A, Cabanillas F, McLaughlin P, et al.: Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. Ann Oncol 2000, 11(Suppl 1):137-140.
15. Horsman DE, Okamoto I, Ludkovski O, et al.: Follicular lymphoma lacking the t(14, 18)(q32, q21): identification of two, disease subtypes. Br J Haematol 2003, 120:424-433.
16. Barrans SL, Evans PA, O'Connor SJ, et al.: The t(14, 18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 2003, 9:2133-2139.
17. Barrans SL, O'Connor SJ, Evans PA, et al.: Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 2002, 117:322-332.
18. Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
19. Rosenwald A, Wright G, Chan WC, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947.
20. Hans CP, Weisenburger DD, Greiner TC, et al.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-282.
21. Pasqualucci L, Migliazza A, Ye BH, Dalla-Favera R: Transcriptional deregulation of mutated BCL6 alleles by loss of negative autoregulation in diffuse large B cell lymphoma. Ann N Y Acad Sci 2003, 987:314-315.
22. Lossos IS, Jones CD, Warnke R, et al.: Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001, 98:945-951.
23. Bertoni F, Zucca E, Cotter FE: Molecular basis of mantle cell lymphoma. Br J Haematol 2004, 124:130-140.
24. Thomazy VA, Luthra R, Uthman MO, et al.: Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas. J Mol Diagn 2002, 4:201-208.
25. Hui P, Howe JG, Crouch J, et al.: Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leuk Lymphoma 2003, 44:1385-1394.
26. Rosenwald A, Wright G, Wiestner A, et al.: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003, 3:185-97.
27. Fang NY, Greiner TC, Weisenburger DD, et al.: Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci U S A 2003, 100:5372-5377.
28. Dierlamm J, Baens M, Wlodarska I, et al.: The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11, 18)(q21, q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999, 93:3601-3609.
29. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al.: Resistance of t(11, 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001, 357:39-40.
30. Maes B, De Wolf-Peeters C: Marginal zone cell lymphoma: an update on recent advances. Histopathology 2002, 40:117-126.
31. Liu H, Ye H, Dogan A, et al.: T(11, 18)(q21, q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001, 98:1182-1187.
32. Streubel B, Lamprecht A, Dierlamm J, et al.: t(14, 18)(q32, q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003, 101:2335-2339.
33. Starostik P, Patzner J, Greiner A, et al.: Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002, 99:3-9.
34. Stilgenbauer S, Bullinger L, Lichter P, et al.: Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002, 16:993-1007.
35. Dogan A, Isaacson PG: Splenic marginal zone lymphoma. Semin Diagn Pathol 2003, 20:121-127.
36. Dyer MJ, Oscier DG: The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 2002, 16:973-984.
37. Wiestner A, Rosenwald A, Barry TS, et al.: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003, 101:4944-4951.
38. Orchard JA, Ibbotson RE, Davis Z, et al.: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004, 363:105-111.
39. Thomas RK, Re D, Wolf J, Diehl V, Part I: Hodgkin's lymphoma: molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol 2004, 5:11-18.
40. Bellan C, Lazzi S, De Falco G, et al.: Burkitt's lymphoma: new insights into molecular pathogenesis. J Clin Pathol 2003, 56:188-192.
41. Haralambieva F, Banham AH, Bastard C, et al.: Detection by the fluorescence in situ hybridization technique of MYC translocation in paraffin-embedded lymphoma biopsy samples. Br J Haematol 2003, 121:49-56.
42. Schop RF, Kuehl WM, Van Wier SA, et al.: Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocation but have frequent 6q deletions. Blood 2002, 100:2996-3001.
43. Morris SW, Xue L, Ma Z, Kinney MC: Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. Br J Haematol 2001, 113:275-295.
44. Cataldo KA, Jalal SM, Law ME, et al.: Detection of t(2, 5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol 1999, 23:1386-1392.
45. Gascoyne RD, Lamant L, Martin-Subero JI, et al.: ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003, 102:2568-2573.
46. Cessna MH, Zhou H, Sanger WG, et al.: Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002, 15:931-938.
47. Zettl A, Ott G, Makulik A, et al.: Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002, 161:1635-1645.
48. Belhadj K, Reyes E, Farcet JP, et al.: Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003, 102:4261-4269.
49. Elenitoba-Johnson KS, Bohling SD, Mitchell RS, et al.: PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn 2000, 2:92-96.
50. Basecke J, Griesinger F, Trumper L, Brittinger G: Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 2002, 81:64-75.
51. Bagg A: Role of molecular studies in the classification of lymphoma. Expert Rev Mol Diagn 2004, 4:83-97.